Rheumatoid arthritis: trials for referral
425 open trials in the registries we read. Each row links to its registry record.
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Where the open trials are
Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.
400 trials shown · Showing the 400 most recently updated of 425 open trials.
Phase 226 sites
RecruitingGeorgia, Mauritius, United States, South Africa
NCT07779616
Study of PTC844 in Participants With Active Rheumatoid Arthritis
PTC Therapeutics
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 10 sites
Not yet recruiting
NCT07923747
An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)
Novartis Pharmaceuticals
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 11 site
RecruitingAustralia
NCT07649265
A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
Otsuka Pharmaceutical Development & Commercialization, Inc.
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
Not yet recruitingChina
NCT07901764
MYTP01 for Immune-Mediated Diseases
Zhejiang Provincial People's Hospital
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govNo phase2 sites
RecruitingUnited States
NCT06631638
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
DePuy Orthopaedics
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 1/223 sites
RecruitingAustralia, Germany, Spain, United Kingdom, Sweden, United States
NCT07295847
A Study of AZD0120 in Autoimmune Diseases
AstraZeneca
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 124 sites
RecruitingAustralia, Belgium, China, Colombia, Spain, Georgia
NCT07363590
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Merck Sharp & Dohme LLC
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 1/212 sites
RecruitingUnited States
NCT06733935
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nkarta, Inc.
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.govPhase 10 sites
Not yet recruiting
NCT07906145
A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Diseases
Shanghai Qilu Pharmaceutical Research and Development Center LTD
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.govPhase 20 sites
Not yet recruiting
NCT07904754
Platform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid Arthritis
AbbVie
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govPhase 1/21 site
Not yet recruitingEgypt
NCT07901309
Efficacy and Safety of Dapagliflozin as an Adjunct to Conventional Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis
Tanta University
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 134 sites
RecruitingAustralia, Belgium, Brazil, China, Germany, Spain
NCT07201558
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
AstraZeneca
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 20 sites
Not yet recruiting
NCT07895524
A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004)
Merck Sharp & Dohme LLC
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govPhase 23 sites
RecruitingCanada
NCT06599658
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
McGill University Health Centre/Research Institute of the McGill University Health Centre
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govPhase 1/239 sites
RecruitingBelgium, Brazil, Switzerland, China, Germany, Spain
NCT07412704
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Bristol-Myers Squibb
Registry updated 23 Oct 2026
Registry record: ClinicalTrials.govPhase 18 sites
RecruitingBulgaria, Germany, Georgia, Moldova, Romania, Ukraine
NCT07533955
A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
Jade Biosciences, Inc.
Registry updated 23 Oct 2026
Registry record: ClinicalTrials.govPhase 232 sites
RecruitingSerbia, United States, South Africa
NCT07409103
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Elevara Medicines Limited
Registry updated 23 Oct 2026
Registry record: ClinicalTrials.govPhase 18 sites
RecruitingAustralia, Georgia, New Zealand, South Africa
NCT06647069
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
Sanofi
Registry updated 21 Oct 2026
Registry record: ClinicalTrials.govPhase 11 site
RecruitingChina
NCT06978647
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
China Immunotech (Beijing) Biotechnology Co., Ltd.
Registry updated 21 Oct 2026
Registry record: ClinicalTrials.govPhase 11 site
RecruitingAustralia
NCT07712939
A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
Candid Therapeutics
Registry updated 21 Oct 2026
Registry record: ClinicalTrials.govPhase 12 sites
RecruitingGreece, United States
NCT05003934
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion and Intra-Articular Injection for RA
The Foundation for Orthopaedics and Regenerative Medicine
Registry updated 20 Oct 2026
Registry record: ClinicalTrials.govPhase 14 sites
RecruitingGermany, Italy
NCT06994143
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis
Cullinan Therapeutics Inc.
Registry updated 20 Oct 2026
Registry record: ClinicalTrials.govPhase 115 sites
RecruitingJapan, United States
NCT07607964
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
AbbVie
Registry updated 20 Oct 2026
Registry record: ClinicalTrials.govPhase 135 sites
RecruitingCanada, China, Germany, Spain, France, United Kingdom
NCT06916806
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
AstraZeneca
Registry updated 19 Oct 2026
Registry record: ClinicalTrials.govPhase 1/210 sites
RecruitingGermany, Spain, United Kingdom
NCT07473154
Controlling Hyperactive Immunity With Long-lived Lymphocytes
Quell Therapeutics Limited
Registry updated 19 Oct 2026
Registry record: ClinicalTrials.govPhase 235 sites
RecruitingBelgium, Brazil, Germany, Denmark, Spain, France
NCT07620392
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Hoffmann-La Roche
Registry updated 16 Oct 2026
Registry record: ClinicalTrials.govPhase 265 sites
RecruitingArgentina, Belgium, Brazil, Germany, Denmark, Spain
NCT07137598
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Hoffmann-La Roche
Registry updated 16 Oct 2026
Registry record: ClinicalTrials.govNo phase0 sites
Not yet recruiting
NCT07870564
the Effect and Mechanism of Percutaneous Auricular Electrical Stimulation in Preventing Central Sensitization Pain in Patients With Rheumatoid Arthritis
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Registry updated 15 Oct 2026
Registry record: ClinicalTrials.govPhase 123 sites
Not yet recruitingBelgium, Germany, France, Netherlands, Poland, United States
NCT07873931
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Bristol-Myers Squibb
Registry updated 14 Oct 2026
Registry record: ClinicalTrials.govPhase 12 sites
RecruitingItaly
NCT07245992
A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Philogen S.p.A.
Registry updated 14 Oct 2026
Registry record: ClinicalTrials.gov
The same sites as a list
- United States81 open trials
- China52 open trials
- France46 open trials
- Germany43 open trials
- Egypt28 open trials
- Spain27 open trials
- Netherlands25 open trials
- Italy24 open trials
- Poland20 open trials
- Australia17 open trials
- Canada17 open trials
- United Kingdom16 open trials
- Belgium16 open trials
- Denmark16 open trials
- Brazil11 open trials
- Türkiye11 open trials
- Romania9 open trials
- Bulgaria9 open trials
- Japan8 open trials
- Georgia7 open trials
- Sweden7 open trials
- Moldova6 open trials
- South Korea6 open trials
- Austria6 open trials
- Portugal6 open trials
- Ukraine5 open trials
- Switzerland5 open trials
- Mexico5 open trials
- Hungary5 open trials
- Czechia5 open trials
- Norway5 open trials
- South Africa4 open trials
- Serbia3 open trials
- New Zealand3 open trials
- Argentina3 open trials
- Puerto Rico3 open trials
- Israel3 open trials
- Finland3 open trials
- Pakistan3 open trials
- Taiwan2 open trials
- Greece2 open trials
- Hong Kong2 open trials
- Chile2 open trials
- Singapore2 open trials
- Monaco2 open trials
- Iraq2 open trials
- Mauritius1 open trial
- Peru1 open trial
- Colombia1 open trial
- Thailand1 open trial
- Bosnia and Herzegovina1 open trial
- Slovakia1 open trial
- United Arab Emirates1 open trial
- India1 open trial
- Panama1 open trial
- Tunisia1 open trial
- Armenia1 open trial
- Iceland1 open trial
Who treats this
Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.
Manchester University NHS Foundation Trust
Manchester, United Kingdom
3 trials · 28 publications · ROR
What changed in the last 7 days
Registry facts, one per line, newest first.
Status changed: Running, not recruiting → Completed
Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
NCT02281747 · No phase · United States
Source: ClinicalTrials.govOpened for recruitment
Study of PTC844 in Participants With Active Rheumatoid Arthritis
NCT07779616 · Phase 2 · Georgia, Mauritius, United States, South Africa
Source: ClinicalTrials.govOpened for recruitment
A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis
NCT07433335 · Phase 1 · Georgia, Moldova, Romania
Source: ClinicalTrials.govOpened for recruitment
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
NCT07258849 · Phase 1 · Germany, United States
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis
NCT07052032 · Phase 1 · Moldova, Romania, Ukraine
Source: ClinicalTrials.govOpened for recruitment
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
NCT06972446 · Phase 2 · Canada, Czechia, Germany, Spain, Hungary, South Korea
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
A Study With CIT-013 in RA Patients
NCT06567470 · Phase 2 · Belgium, Germany, Spain, Netherlands, Poland
Source: ClinicalTrials.govClosed for recruitment
NCT06293365 · Phase 2 · Argentina, Canada, Czechia, Germany, Spain, Hungary
Source: ClinicalTrials.govPhase changed: Phase 4 → Phase 3
NCT05814627 · Phase 3 · Argentina, Belgium, Bulgaria, Brazil, Canada, Chile
Source: ClinicalTrials.govOpened for recruitment
Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)
NCT05092984 · Phase 3 · Germany, France
Source: ClinicalTrials.govClosed for recruitment
Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
NCT04870203 · Phase 3 · France, Monaco
Source: ClinicalTrials.govPhase changed: Phase 1 → Phase 2
Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
NCT03938701 · Phase 2 · Netherlands
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
NCT02765074 · Phase 4 · France
Source: ClinicalTrials.govClosed for recruitment
Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)
NCT05092984 · Phase 3 · Germany, France
Source: ClinicalTrials.govOpened for recruitment
Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
NCT04870203 · Phase 3 · France, Monaco
Source: ClinicalTrials.govOpened for recruitment
NCT06293365 · Phase 2 · Argentina, Canada, Czechia, Germany, Spain, Hungary
Source: ClinicalTrials.govClosed for recruitment
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
NCT06972446 · Phase 2 · Canada, Czechia, Germany, Spain, Hungary, South Korea
Source: ClinicalTrials.gov
Show more
Status changed: Recruiting → Not yet recruiting
A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis
NCT07433335 · Phase 1 · Georgia, Moldova, Romania
Source: ClinicalTrials.govStatus changed: Recruiting → Not yet recruiting
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
NCT07258849 · Phase 1 · Germany, United States
Source: ClinicalTrials.govNew in the registry
GenAI-Assisted Rheumatoid Arthritis Bone Erosion Risk Assessment and DMARD Selection
NCT07914907 · No phase · China
Source: ClinicalTrials.govNew in the registry
Overactive Bladder Symptoms and Urinary Incontinence In Women With Rheumatoid Arthritis
NCT07916623 · No phase
Source: ClinicalTrials.govPhase changed: No phase → Phase 2/3
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
NCT07403188 · Phase 2/3 · Germany, United States
Source: ClinicalTrials.gov
New reviews, guidelines and randomised trials in PubMed
Randomised trial
Clinical efficacy of warm acupuncture on wind-cold-dampness rheumatoid arthritis.
Malawi medical journal : the journal of Medical Association of Malawi · PubMed
Systematic review
PharmacoEconomics · PubMed
Meta-analysis
Current rheumatology reviews · PubMed
Results card
Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.
No phaseEnded 4 Nov 2026
Completed521292 participants
NCT02281747
Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
No phaseEnded 1 Oct 2026
Completed60 participants
NCT05788705
Efficacy of JAK STAT Pathways Inhibitors in Treatment of Patients With Rheumatoid Arthritis
No phaseEnded 26 Aug 2026
Phase 3Ended 20 Aug 2026
Completed459 participants
NCT06020144
A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs
Phase 2Ended 11 Aug 2026
No phaseEnded 10 Aug 2026
Completed50 participants
NCT07264101
Validity And Reliability Of The Four Square Step Test In Individuals With Rheumatoid Arthritis
No phaseEnded 24 Jul 2026
Completed228 participants
NCT06993935
Health Literacy, Rational Drug Use, and Cyberchondria in Rheumatic Diseases
Phase 2Ended 20 Jul 2026
Completed40 participants
2023-510258-17-00
Phase IIa Proof-of-Concept Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients with Rheumatoid Arthritis
Phase 2Ended 20 Jul 2026
Completed40 participants
NCT06565273
Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis
No phaseEnded 17 Jul 2026
Completed195 participants
NCT01307384
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
Phase 3Ended 15 Jul 2026
No phaseEnded 15 Jul 2026
Completed1500 participants
NCT03631225
The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
No phaseEnded 10 Jul 2026
Phase 2Ended 18 Jun 2026
Completed20 participants
2024-514026-23-00
Inhibition of JAK enzymes in early stage joint inflammation
Phase 2Ended 16 Jun 2026
Phase 2Ended 5 Jun 2026
Stopped early35 participants
NCT06859294
A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis
Reason given: The interim analysis data failed to demonstrate the intended treatment effect.
Phase 2Ended 4 Jun 2026
Completed40 participants
NCT07715045
Umbilical Cord Mesenchymal Stromal Cell Secretome for Moderate Rheumatoid Arthritis
Phase 2/3Ended 1 Jun 2026
No phaseEnded 29 May 2026
Completed3000 participants
NCT03971253
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
No phaseEnded 14 May 2026
Completed302 participants
NCT06714461
A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia
Show more
Phase 2Ended 12 May 2026
Stopped early49 participants
NCT07100938
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
Reason given: Sponsor has concluded that patients are unlikely to derive sufficient benefit from treatment with BGB-45035 to support continuation of the clinical development program due to unfavored benefit/risk profile.
No phaseEnded 11 May 2026
Completed54 participants
NCT07844564
Effects of Nonsurgical Periodontal Treatment on GCF Calprotectin and IL-10 in Rheumatoid Arthritis
Phase 2Ended 11 May 2026
Completed172 participants
2024-514981-37-00
A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy and safety of oral AP1189 administered at the doses of 40, 70, or 100 mg for 12 weeks in combination with methotrexate, in DMARD-naïve participants with early rheumatoid arthritis and active inflammation.
Phase 1Ended 11 May 2026
Stopped early55 participants
NCT06031415
Study of GS-0272 in Participants With Rheumatoid Arthritis
Reason given: Study terminated due to lack of efficacy.
Phase 2Ended 22 Apr 2026
Completed164 participants
NCT05848258
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
Phase 3Ended 13 Apr 2026
Phase 3Ended 13 Apr 2026
Completed192 participants
NCT06738719
A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis
No phaseEnded 3 Apr 2026
Completed50 participants
NCT07167784
Ecological Momentary Assessment and Physical Activity in Patients With Inflammatory Rheumatic Diseases
Phase 1Ended 31 Mar 2026
Paused16 participants
2025-522531-34-00
Methotrexate PK (in combination with Novobiocin) in RA patients
No reason given in the registry.
No phaseEnded 30 Mar 2026
Completed155 participants
NCT05323591
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
No phaseEnded 29 Mar 2026
Completed90 participants
NCT07359326
The Effect of Cold Application in Patients With Rheumatoid Arthritis
No phaseEnded 25 Mar 2026
Completed26 participants
NCT06767618
Investigation of Upper Extremity Functions in Patients With Rheumatoid Arthritis
No phaseEnded 5 Mar 2026
Completed6967 participants
NCT07580092
Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease
No phaseEnded 5 Mar 2026
Stopped early67 participants
NCT05002959
TESS V3 Modular Total Shoulder System PMCF
Reason given: Termination of PMCF study due to product discontinuation (commercial reasons)
No phaseEnded 4 Mar 2026
No phaseEnded 2 Mar 2026
No phaseEnded 1 Mar 2026
Completed460 participants
NCT07277491
Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity
No phaseEnded 28 Feb 2026
Completed57 participants
NCT07301892
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Phase 4Ended 25 Feb 2026
Completed118 participants
NCT06625242
A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis
No phaseEnded 23 Feb 2026
Phase 3Ended 20 Feb 2026
Phase 3Ended 20 Feb 2026
Completed548 participants
2024-510826-16-00
A study to compare efficacy, pharmacokinetics, safety and immunogenicity of MB04 [proposed etanercept biosimilar] to Enbrel® [EU-sourced] in rheumatoid arthritis
Phase 1Ended 16 Feb 2026
Completed72 participants
NCT05638854
A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis
No phaseEnded 1 Feb 2026
Completed87 participants
NCT04968405
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
No phaseEnded 31 Jan 2026
Completed90 participants
NCT06873607
Effectiveness Evaluation of a Mobile Application for Rheumatoid Arthritis
Phase 4Ended 29 Jan 2026
Completed224 participants
NCT03227419
Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders
No phaseEnded 14 Jan 2026
Completed340 participants
NCT04474392
Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins
Phase 2Ended 12 Jan 2026
Completed154 participants
NCT03604406
The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept
No phaseEnded 5 Jan 2026
Completed16 participants
NCT06555562
Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis
No phaseEnded 31 Dec 2025
No phaseEnded 31 Dec 2025
Completed26 participants
NCT05545839
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
No phaseEnded Dec 2025
Withdrawn before start0 participants
NCT02450396
Pregnancy and Medically Assisted Conception in Rare Diseases
Reason given: Abandonment of the study project
No phaseEnded 31 Dec 2025
No phaseEnded 31 Dec 2025
No phaseEnded 31 Dec 2025
No phaseEnded 28 Dec 2025
Completed55 participants
NCT06753552
Combined Effect of Underwater Ultrasound
- Combined effect of underwater ultrasound and custom-made insoles in rheumatoid arthritis: a randomized controlled trial. · Clinical rheumatology, 2026
Phase 1/2Ended 6 Dec 2025
Completed48 participants
NCT07349420
EF-M2 (Immutalon) Multiple Ascending Dose Study in Moderate-to-Severe Rheumatoid Arthritis
Phase 3Ended 2 Dec 2025
Completed415 participants
2023-506664-14-00
A randomised, double-blind, multicentre study comparing the efficacy, safety and immunogenicity of proposed Abatacept biosimilar (DRL_AB) with Orencia® administered by the intravenous route as an add-on to methotrexate in the treatment of patients with moderate to severe rheumatoid arthritis
No phaseEnded 1 Dec 2025
No phaseEnded 30 Nov 2025
Not medical advice. fetched 10 Nov 2026